middle.news
PainChek Accelerates US Rollout with First Sabra Deployments and 5.9% ARR Growth
9:58am on Wednesday 29th of July, 2026 AEST
•
Healthcare
Read Story
PainChek Accelerates US Rollout with First Sabra Deployments and 5.9% ARR Growth
9:58am on Wednesday 29th of July, 2026 AEST
Key Points
Implemented ARR rose 5.9% to $4.46 million
First two three-year US deployments under Sabra deal
Customer receipts increased 27% quarter-on-quarter
Net operating cash outflow improved by $689,000
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Painchek (ASX:PCK)
OPEN ARTICLE